| Literature DB >> 35937852 |
Laura Privitera1,2, Irene Paraboschi1,2, Divyansh Dixit3, Owen J Arthurs4,5, Stefano Giuliani1,2,6.
Abstract
Fluorescence guided surgery, augmented reality, and intra-operative imaging devices are rapidly pervading the field of surgical interventions, equipping the surgeon with powerful tools capable of enhancing the surgical visualisation of anatomical normal and pathological structures. There is a wide range of possibilities in the adult population to use these novel technologies and devices in the guidance for surgical procedures and minimally invasive surgeries. Their applications and their use have also been increasingly growing in the field of paediatric surgery, where the detailed visualisation of small anatomical structures could reduce procedure time, minimising surgical complications and ultimately improve the outcome of surgery. This review aims to illustrate the mechanisms underlying these innovations and their main applications in the clinical setting.Entities:
Keywords: augmented reality; fluorescence-guided surgery; general surgery; image-guided surgery; intra-operative visualisation; novel devices; optical imaging; paediatric surgery
Year: 2022 PMID: 35937852 PMCID: PMC9294338 DOI: 10.1515/iss-2021-0028
Source DB: PubMed Journal: Innov Surg Sci ISSN: 2364-7485
Summary of clinical trials completed or active on molecular target fluorescent-guided surgery in the adult population.
| Identifier | Title | Location | Drug | Status | Results |
|---|---|---|---|---|---|
| NCT02113202 [ | Molecular fluorescence endoscopy in patients with familial adenomatous polyposis, using Bevacizumab-IRDye800CW | Netherlands | Bevacizumab-IRDye800CW | Completed | Near-infrared fluorescence molecular endoscopy is clinically feasible as a real-time, red-flag technique for detection of colorectal adenomas. |
| NCT01972373 [ | Visualisation of rectal cancer during endoscopy, using a fluorescent tracer | Netherlands | Bevacizumab-IRDye800CW | Completed | Quantitative fluorescence endoscopy is a promising technique to aid clinical response assessment in patients with locally advanced rectal cancer and warrants further validation in larger clinical trials. |
| NCT01508572 [ | VEGF-targeted fluorescent tracer imaging in breast cancer | Netherlands | Bevacizumab-IRDye800CW | Completed | Systemic administration of the Bevacizumab–IRDye800CW tracer is safe for breast cancer guidance and confirms tumour and tumour margin uptake. |
| NCT03913806 [ | Fluoresence image guided surgery with a VEGF-targeted tracer in soft-tissue sarcomas in humans approach with Bevacizumab-IRDye 800CW | Netherlands | Bevacizumab-IRDye800CW | Completed | Fluorescence-guided surgery using 10 mg of Bevacizumab-800CW is feasible and safe for intraoperative imaging of soft-tissue sarcoma, allowing tumour detection and margin assessment intraoperatively. |
| NCT02736578 [ | Cetuximab-IRDye 800CW and intraoperative imaging in finding pancreatic cancer in patients undergoing surgery | USA | Cetuximab-IRDye800 | Terminated | First-in-human study to evaluate the use of multimodality molecular imaging in patients undergoing surgery for pancreatic cancer. The study proves the safety and feasibility of intraoperative, tumour-specific detection of PDAC using Cetuximab-IRDye800 with multimodal molecular imaging of the primary tumour and metastases was demonstrated. |
| NCT02129933 [ | VEGF-targeted fluorescence near-infrared (NIR) endoscopy in (Pre)malignant oesophageal lesions | Netherlands | Bevacizumab-IRDye800CW | Completed | The concurrent use of VEGFA-guided NIR fluorescence molecular endoscopy and high-definition white-light endoscopy, following tracer administration, can be used to detect dysplastic and early cancerous lesions in patients with Barrett’s oesophagus. |
| NCT02855086 [ | Cetuximab-IRDye 800CW in detecting tumors in patients with malignant glioma undergoing surgery | USA | Cetuximab-IRDye 800CW | Terminated | This first-in-human study demonstrates the feasibility and safety of antibody based imaging for contrast-enhancing glioblastomas. |
| NCT02743975 | Near-infrared image guided surgery in pancreatic adenocarcinoma | Netherlands | Bevacizumab-800CW | Terminated | The study was terminated due to insufficient tumour-to-background ratios in the first three dose groups (4.5; 10; 25 mg). |
| NCT01987375 [ | Cetuximab IRDye800 study as an optical imaging agent to detect cancer during surgical procedures | USA | Cetuximab-IRDye800 | Terminated | Commercially available antibodies can be fluorescently labelled and safely administered to humans, potentially improving outcomes in clinical oncology. |
| NCT03134846 [ | Image guided surgery for margin assessment of head and neck cancer using Cetuximab-IRDye800CW conjugate | Netherlands | Cetuximab-IRDye800CW | Recruiting | Authors were able to use a lower dose Cetuximab-800CW than previously described, while remaining a high sensitivity for tumour detection due to application of equipment optimised for IRDye800CW detection. |
| NCT04459065 [ | Evaluation of IRDye800CW-nimotuzumab in lung cancer surgery | Canada | IRDye800CW-nimotuzumab | Recruiting | Preliminary results on pre-clinical studies demonstrate that nimotuzumab conjugated to IRDye800CW is safe and does not exhibit toxicities commonly associated with EGFR targeting antibodies. |
| NCT03925285 [ | Image guided surgery in sinonasal inverted papilloma | Netherlands | Bevacizumab-800CW | Recruiting | Preliminary results show that a fluorescence grid analysis could serve as a valid method to evaluate fluorescence molecular imaging in piecemeal surgeries. |
Figure 1:AR in the surgical field through the visualisation of data projected on a screen (panel A) or with a head-mounted display (black arrow in panel B) that superimposed objects onto real-time images (panel B). The picture shows a tumour (yellow) before surgical resection. The area in orange shows the extension of the tumour into the liver (red). The bowel is marked in light blue.
Figure 2:Schematic representation of contrast-enhanced ultrasound mechanism of action, with intravenously administered contrast agent. Ultrasound contrast agents consist of gas-filled microbubbles (1–10 µm) with a lipid, protein, or polymer shell. The pressure changes induced by the ultrasonic waves lead microbubbles to contract (compression) and expand (rarefaction) to a higher degree compared to the surrounding tissues. This, along with the impedance mismatch between the microbubble and surrounding fluid caused by the gas, makes the bubbles highly echogenic. Abbreviations: RBC, red blood cell; EC, endothelial cell.
Figure 3:Schematic representation of photoacoustic imaging mechanism of action. The absorption of light by endogenous chromophores (or pigments) generates heat, leading to a pressure change. The resulting fleeting expansions generate an ultrasound wave which can then be detected and used to produce clear, high-resolution images of biological structures.
Summary of principle of mechanism, advantages and limitations of the investigated intra-operative devices.
| Intra-operative devices | Principle | Advantages | Limitations |
|---|---|---|---|
| Augmented reality (AR) | Superimposition of pre-operative images onto the surgical field |
Real-time enhancement of the surgical procedure Better appreciation of 3D structures Possibility of tactile feedback Future educational advancement |
High costs Potential registration errors Lack of devices Protection of personal identifiable data |
| Intraoperative contrast-enhanced ultrasound (CEUS) | CEUS combines ultrasound imaging with intravenous contrast to improve the visualisation of blood vessels and organs. |
Non-invasive and non-ionising Real-time detection May offer improved diagnostic performance than conventional ultrasound Safety profile of contrast agents Absence of specific patient preparation/sedation Possibility of bedside access |
Small risk of an allergic reaction Instability of contrast agents Operator dependent Location of the lesion and patients’ characteristics affect images acquisition Limited sonic window and scattering of the sound waves due to anatomical changes Requires experience and training |
| Ultra-high frequency ultrasound (UHFUS) | Novel matrix ultrasound transducers with frequencies ranging from 30 to 100 MHz |
Non-invasive and non-ionising Real-time detection Higher spatial resolution Better quality of images from superficial layers Absence of specific patient preparation/sedation |
Reduced penetration depth Image acquisition can be affected by air Operator dependent Requires experience and training Higher costs |
| Intraoperative magnetic resonance imaging (MRI) | Magnetic resonance imaging obtained during surgery |
High-resolution images Real-time guidance during surgery Allows surgeons to perform safer and more effective surgery of some tumours |
High cost of MRI systems Side effects to contrast agents Need to prevent hypothermia during long procedures Limited operative positioning Specific equipment requirement |
| Photoacoustic imaging (PAI) | Non-invasive technique based on the absorption of non-ionising laser pulser by endogenous light-absorbing molecules |
Non-invasive Near real-time imaging capability Relies mainly on endogenous contrast High-quality 3D anatomical images Greater specificity than ultrasound imaging Can provide functional information |
Penetration depth is limited by optical and acoustic attenuations Need for highly sensitive suitably broadband receivers Lack of suitable laser systems |